A gene expression signature predicts recurrence-free survival in meningioma

BACKGROUND: Meningioma is the most common primary brain tumor and has a variable risk of local recurrence. While World Health Organization (WHO) grade generally correlates with recurrence, there is substantial within-grade variation of recurrence risk. Current risk stratification does not accurately...

Descripción completa

Detalles Bibliográficos
Autores principales: Olar, Adriana, Goodman, Lindsey D., Wani, Khalida M., Boehling, Nicholas S., Sharma, Devi S., Mody, Reema R., Gumin, Joy, Claus, Elizabeth B., Lang, Frederick F., Cloughesy, Timothy F., Lai, Albert, Aldape, Kenneth D., DeMonte, Franco, Sulman, Erik P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882319/
https://www.ncbi.nlm.nih.gov/pubmed/29662628
http://dx.doi.org/10.18632/oncotarget.24498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882319/
https://www.ncbi.nlm.nih.gov/pubmed/29662628
http://dx.doi.org/10.18632/oncotarget.24498

Ejemplares similares